MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CBIO — Crescent Biopharma, Inc. Common Stock
NasdaqCrescent Biopharma, Inc. Common Stock
$14.32
+0.06(+0.42%)
- O
- 14.48
- H
- 14.55
- L
- 14.07
- V
- 276.35K
⏱️ End-of-day dataAs of Oct 2, 2026
CBIO — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2023-09-30 | 2023-06-30 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,023.00 | 2,023.00 |
| Cash | 189,163.00 | 213,192.00 | 133,265.00 | 152,645.00 | N/A | N/A |
| Cash And Cash Equivalents | 189,163.00 | 213,192.00 | 133,265.00 | 152,645.00 | 2,228.00 | 6,923.00 |
| Accounts Receivable | 0.00 | 18,000.00 | N/A | N/A | 0.00 | 0.00 |
| Prepaid Assets | 5,027.00 | 4,185.00 | N/A | N/A | 1,169.00 | N/A |
| Other Current Assets | 1,373.00 | 1,278.00 | 1,298.00 | 1,582.00 | 535.00 | 697.00 |
| Total Current Assets | 195,563.00 | 236,655.00 | 134,563.00 | 154,227.00 | 5,132.00 | 7,620.00 |
| Properties | 2,301.00 | 2,315.00 | 2,346.00 | 1,800.00 | N/A | 0.00 |
| Other Non Current Assets | 1,266.00 | 1,323.00 | 1,360.00 | 1,406.00 | 4,832.00 | 4,774.00 |
| Total Non Current Assets | 3,567.00 | 3,638.00 | 3,706.00 | 3,206.00 | 4,832.00 | 4,774.00 |
| Total Assets | 199,130.00 | 240,293.00 | 138,269.00 | 157,433.00 | 9,964.00 | 12,394.00 |
| Accounts Payable | 1,190.00 | 9,997.00 | 2,561.00 | 1,648.00 | 158.00 | 5.00 |
| Accrued Expenses | 2,617.00 | 3,223.00 | 6,214.00 | 6,042.00 | 917.00 | 568.00 |
| Short Term Debt | 453.00 | 435.00 | 417.00 | 211.00 | N/A | N/A |
| Deferred Revenue | 3,117.00 | 4,156.00 | N/A | N/A | N/A | N/A |
| Tax Payable | 0.00 | 8,000.00 | N/A | N/A | N/A | 1,500.00 |
| Pensions | 1,816.00 | 5,121.00 | 2,751.00 | 1,566.00 | 708.00 | 720.00 |
| Other Current Liabilities | 5,000.00 | 5,000.00 | 2,088.00 | 2,096.00 | N/A | N/A |
| Total Current Liabilities | 14,193.00 | 36,072.00 | 20,304.00 | 16,746.00 | 1,783.00 | 2,793.00 |
| Long Term Debt | 1,090.00 | 1,209.00 | 1,324.00 | 1,433.00 | N/A | N/A |
| Total Non Current Liabilities | 1,090.00 | 1,209.00 | 1,324.00 | 1,433.00 | 4,664.00 | 37,915.00 |
| Total Liabilities | 15,283.00 | 37,281.00 | 21,628.00 | 18,179.00 | 6,447.00 | 40,708.00 |
| Common Stock | 28.00 | 28.00 | 14.00 | 14.00 | 37.00 | 37.00 |
| Retained Earnings | -195,092.00 | -171,809.00 | -79,412.00 | -54,805.00 | -414,724.00 | -413,148.00 |
| Total Shareholders Equity | 183,847.00 | 203,012.00 | 116,641.00 | 139,254.00 | 3,517.00 | -28,314.00 |
| Additional Paid In Capital | 374,911.00 | 370,793.00 | 192,039.00 | 190,045.00 | 384,895.00 | 384,797.00 |
| Cash Equivalents | N/A | N/A | N/A | N/A | 2,228.00 | 6,923.00 |
| Other Receivables | N/A | N/A | N/A | N/A | 1,200.00 | N/A |
| Derivative Product Liabilities | N/A | N/A | N/A | N/A | 4,664.00 | 4,606.00 |